|
|
 |
January 24, 2008 |
Now Available:
Download the podcast of Dr. Gaylis's video presentation
With biweekly and special edition newsletters, Musculoskeletal Report is the top online resource for staying abreast of the most current and clinically relevant information in the field of musculoskeletal disease and treatment.
MSK Report provides cutting-edge scientific updates through in-depth interviews, on-location coverage of medical meetings, expert-led panel discussions, and live newscasts. With an editorial board of internationally recognized thought leaders, MSK Report is positioned to provide unparalleled quality news reporting with the highest level of credibility.
Consumer News: Learn what your patients are reading in the popular press
NSAIDs No Better for Low Back Pain
Acetaminophen has been found to provide comparable relief to nonsteroidal anti-inflammatory drugs (NSAIDs) for low back pain...
New from PubMed: Keep up-to-date with what is on PubMed
Characteristic Electron Microscopic Findings in the Skin of Patients With Fibromyalgia
The lower pain threshold of fibromyalgia patients may be caused by abnormal unmyelinated nerve fibers and associated Schwann cells...
MSK Video Report:
The Whys and Wherefores of Infusion Therapy
Dr. Norman Gaylis investigates the risks and benefits of in-office infusion therapy for RA patients....
Arthritis: TNFα Inhibitors Can Be Used Again After Treatment of TB Flare
TNFα inhibitors can be safely readministered after either a flare of latent TB or a new TB infection and should be considered an option in patients with otherwise uncontrollable RA...
Arthritis: Bacterial Gastroenteritis Leads to Joint Pain That Seldom Needs Prescription Treatment
Patients who experience gastrointestinal (GI) symptoms after a bacterial outbreak are more likely to report a diagnosis of arthritis in the ensuing 4 years, but they are not likely to report needing prescription drugs for their joint pain...
BioPharm Business: Abbott's Humira Approved in US for Treatment of Moderate-to-Severe Chronic Plaque Psoriasis
Abbott Laboratories announced it has received US FDA approval to market Humira (adalimumab) for adults with moderate-to-severe chronic plaque psoriasis...
BioPharm Business: ZymoGenetics, Merck Serono Gain Special Protocol Assessment from US FDA for Atacicept (TACI-Ig) in General SLE
ZymoGenetics, Inc and its partner Merck Serono Intl has received agreement from the US FDA for studies that are intended to support an application for marketing authorization of atacicept in the US for the treatment of SLE...